Marketing and distribution? This isn't some new cold remedy we have - this will market and distribute itself. We got here in 5 years WITHOUT big pharma and I figure we don't need their money. We need money but I'd rather go Seaside and other non-pharma deep pockets. We can do this ourselves and in another 5 years be well beyond another measly $1 in gains. Let big pharma stick with good old reliable Tamiflu and the present HIV multi drug cocktail while we bury both.
Oncolytics Biotech (ONCY) is the poster child of your keen observations about big pharma. Brad Thomson has fended off many offers and now approach reporting P3 results shortly. No doubt NNVC will have to travel the same road, but has many more opportunities.